Research ArticleClinical Studies
Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer
HIROOMI OGAWA, TAKUYA SHIRAISHI, TAKUHISA OKADA, YOHEI MIYAMAE, YOKO MOTEGI, KEN SHIRABE and HIROSHI SAEKI
Anticancer Research February 2024, 44 (2) 805-814; DOI: https://doi.org/10.21873/anticanres.16872
HIROOMI OGAWA
1Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan;
TAKUYA SHIRAISHI
1Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan;
TAKUHISA OKADA
1Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan;
YOHEI MIYAMAE
2Department of Surgery, Takasaki General Medical Center, Takasaki, Japan;
YOKO MOTEGI
3General Surgery, Japan Red Cross Maebashi Hospital, Maebashi, Japan;
KEN SHIRABE
4Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan
HIROSHI SAEKI
1Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan;

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer
HIROOMI OGAWA, TAKUYA SHIRAISHI, TAKUHISA OKADA, YOHEI MIYAMAE, YOKO MOTEGI, KEN SHIRABE, HIROSHI SAEKI
Anticancer Research Feb 2024, 44 (2) 805-814; DOI: 10.21873/anticanres.16872
Jump to section
Related Articles
Cited By...
- No citing articles found.





